Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Spain
Summary - Supply Of Human Use Medications Containing The Following Active Ingredients: Vemurafenib, Dornasa Alfa, Vismodegib, Cobimetinib, Alectinib, Emiizumab, Polatuzumab, Pertuzumab/Trastuzumab, Risdiplam, Faricimab, Entrectinib And Satalizumab Through The Negotiated Procedure Without Advertising By Exclusivity.
Deadline - login to view
GT reference number - 113322709
Product classification - Antineoplastic agents
Address - Spain
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 113322709
Document Type - Tender Notices
Description - Description: Supply of human use medications containing the following active ingredients: Vemurafenib, Dornasa Alfa, Vismodegib, Cobimetinib, Alectinib, Emiizumab, Polatuzumab, Pertuzumab/Trastuzumab, Risdiplam, Faricimab, Entrectinib and Satalizumab through the negotiated procedure without advertising by exclusivity.local title:: Suministro de medicamentos de uso humano que contiene los principios activos siguientes: Vemurafenib, Dornasa Alfa, Vismodegib, Cobimetinib, Alectinib, Emicizumab, Polatuzumab, Pertuzumab/Trastuzumab, Risdiplam, Faricimab, Entrectinib y Satralizumab a través del procedimiento negociado sin publicidad por exclusividad.Contract Duration: : 1 YEARContract Type: : Sup
Gt Ref Id - 113322709
Deadline - Nov 30, -0001
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database